NCT05941728

Brief Summary

The goal of this clinical trial is to learn about the effects of avocado consumption on gastrointestinal health in adults with overweight and obesity. The main questions is aims to answer are: How does avocado consumption affect the gut microbiome? How does avocado consumption affect thinking? Are there connections between the microbiome and cognition? Participants will be asked to eat provided meals with and without avocados for three 4-week periods. At the end of each 4-week period, participants will be asked to provide stool samples and complete computer games that assess thinking and memory.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2023

Completed
14 days until next milestone

Study Start

First participant enrolled

July 11, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 12, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

October 13, 2023

Status Verified

October 1, 2023

Enrollment Period

12 months

First QC Date

June 27, 2023

Last Update Submit

October 11, 2023

Conditions

Keywords

AvocadoGastrointestinal microbiomeBile acid profileInflammationThinkingGlycemia

Outcome Measures

Primary Outcomes (4)

  • Fecal microbial species

    Feacalibacterium spp., bacteria capable of producing SCFA and secondary bile acid synthesis measured using metagenomic sequencing

    4 weeks

  • Fecal microbial genes

    Microbial genes involved in short-chain fatty acids and secondary bile acid synthesis measured using metagenomic sequencing

    4 weeks

  • Concentration of fecal bile acids

    Fecal bile acid concentrations using HPLC in avocado and active comparator vs. control,

    4 weeks

  • Concentration of fecal SCFA

    Fecal SCFA concentrations using GC-MS in avocado and active comparator vs. control,

    4 weeks

Secondary Outcomes (3)

  • Cognitive function

    4 weeks

  • Subjective gastrointestinal tolerance via questionnaire

    4 week

  • Digestive health using stool records/Bristol Stool Scale

    4 week

Other Outcomes (5)

  • Fecal microbiome

    4 weeks

  • Inflammation

    4 weeks

  • Intestinal permeability

    up to 4 weeks

  • +2 more other outcomes

Study Arms (3)

Avocado

EXPERIMENTAL

The experimental treatment will contain an avocado. Avocados will be consumed daily for 4 weeks.

Other: Avocado

Fiber + Oil

ACTIVE COMPARATOR

The active comparator will have a snack that mimics the fiber and fatty acid composition found in avocados and will be consumed daily for 4 weeks.

Other: Oil + Fiber

Standard American Diet

SHAM COMPARATOR

The sham comparator contains foods and beverages of a standard American diet and will be consumed daily for 4 weeks.

Other: Average American Diet

Interventions

AvocadoOTHER

The intervention treatment will contain avocado

Avocado

The active comparator will contain a snack with oils and fibers that mimic an avocado

Fiber + Oil

The sham comparator will contain foods/beverages that mimic a standard American Diet

Standard American Diet

Eligibility Criteria

Age25 Years - 74 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must be between the ages of 25 and 74 years old
  • BMI ≥ 25 kg/m2
  • Ability to drop off fecal sample within 15 minutes of defecation
  • /20 or corrected vision

You may not qualify if:

  • Avocado allergy or intolerance
  • Food allergies or intolerances
  • Prior diagnosis of liver or gastrointestinal disease (primary biliary cirrhosis or gallbladder disease, chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers), diabetes, hepatitis, HIV, or cancer
  • Women that are pregnant, have given birth in the previous 12 months or are lactating
  • Individuals that smoke, use tobacco, abuse drugs, or consume \> 2 alcoholic beverages per day.
  • \> 5% weight change in the past month or \> 10% change in the past six months
  • Oral antibiotics during the previous 6 weeks.
  • Currently taking lipid-lowering medications, oral hypoglycemic agents, or insulin.
  • History of malabsorptive or restrictive bariatric surgeries (e.g., gastric bypass, sleeve gastrectomy, adjustable gastric band) or gall bladder removal surgery.
  • Are unable to consume the experimental meals/snacks.
  • Allergic to latex
  • Concurrent enrollment in another dietary, exercise, or medication study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Illinois, Urbana Champaign

Urbana, Illinois, 61801, United States

RECRUITING

MeSH Terms

Conditions

OverweightObesityInflammation

Interventions

OilsDietary Fiber

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Intervention Hierarchy (Ancestors)

LipidsDietary CarbohydratesCarbohydratesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Hannah Holscher, PhD, RD

    University of Illinois Urbana Champaign

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hannah D Holscher, PhD, RD

CONTACT

Maggie Oleksiak, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 27, 2023

First Posted

July 12, 2023

Study Start

July 11, 2023

Primary Completion

July 1, 2024

Study Completion

July 1, 2024

Last Updated

October 13, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations